Anti-HBs gwajin: menene don kuma yadda za'a fahimci sakamakon

Wadatacce

• Menene don
• HBsAg Jarrabawa
• Yaya ake yi
• Fahimtar sakamako

Ana buƙatar gwajin anti-hbs don bincika ko mutumin yana da rigakafi daga kwayar hepatitis B, ko ta samu ta hanyar rigakafi ko kuma ta warkar da cutar.

Ana yin wannan gwajin ne ta hanyar nazarin wani karamin samfurin jini inda ake duba yawan kwayoyi masu kariya daga kwayar hepatitis B a cikin jini .. A yadda aka saba, ana bukatar gwajin anti-hbs tare da gwajin HBsAg, wanda shine gwajin inda kwayar take. a cikin jini kuma saboda haka ana amfani dashi don ganewar asali.

Menene don

Ana amfani da gwajin anti-hbs ne don tantance yadda kwayoyin ke samar da kwayoyin cuta kan furotin da ke jikin kwayar cutar hepatitis B, HBsAg. Don haka, ta hanyar gwajin anti-hbs, likita na iya duba ko an yiwa mutum rigakafin cutar hepatitis B ko a'a, ta hanyar allurar rigakafi, ban da dubawa ko maganin na da inganci ko an warke, lokacin da cutar ta gano hepatitis B ya tabbatar.

HBsAg Jarrabawa

Duk da yake ana bukatar gwajin anti-hbs domin tabbatar da rigakafi da kuma mayar da martani ga magani, likitan ya bukaci gwajin HBsAg don gano ko mutumin ya kamu da cutar ko kuma ya taba mu'amala da kwayar hepatitis B. ana bukatar bincike don gano cutar hepatitis B.

HBsAg furotin ne wanda yake bazuwar kwayar cutar hepatitis B kuma yana da amfani don gano cutar hanta mai saurin ɗauke da cutar B. Yawancin lokaci ana buƙatar gwajin HBsAg tare da gwajin anti-hbs, saboda yana yiwuwa a bincika ko kwayar tana yawo a cikin jini kuma idan kwayar ke aiki a kanta. Lokacin da mutum ya kamu da cutar hepatitis B, rahoton ya kunshi reagent HBsAg, wanda wani muhimmin sakamako ne ga likita, domin ta haka ne zai yiwu a fara magani. Fahimci yadda ake kula da hepatitis B

Yaya ake yi

Don yin gwajin anti-hbs, babu wani shiri ko azumi da ake buƙata kuma ana yin sa ne ta hanyar tattara ƙaramin samfurin jini, wanda aka aika zuwa dakin bincike don bincike.

A dakin gwaje-gwaje, jinin yana yin wani tsarin bincike na serological, wanda a ciki ne ake tabbatar da kasancewar wasu kwayoyi na musamman game da kwayar hepatitis B. Wadannan kwayoyi suna samuwa ne bayan sun hadu da kwayar ko kuma saboda allurar riga-kafi, wanda a ciki ne kwayar take motsa jiki zuwa samar da wadannan kwayoyin cuta, suna ba mutum rigakafi har tsawon rayuwarsa.

San lokacin da yakamata a dauki rigakafin cutar hepatitis B.

Fahimtar sakamako

Sakamakon gwajin anti-hbs ya banbanta gwargwadon yawan kwayar cutar da ke kare kwayar cutar hepatitis B a cikin jini, tare da kimar tunani:

• Anti-hbs maida hankali kasa da 10 mUI / mL - ba sake sakewa ba. Wannan yawan kwayar cutar ba ta isa ta kare cutar ba, yana da muhimmanci mutum ya yi rigakafin cutar. Idan har an riga an gano cutar hepatitis B, wannan maida hankali yana nuna cewa babu magani kuma cewa maganin baya tasiri ko kuma yana matakin farko;
• Mai da hankali kan anti-hbs tsakanin 10 mUI / mL da 100 mUI / mL - wanda ba shi da iyaka ko gamsarwa ga allurar rigakafi. Wannan nitsuwa na iya nuna cewa an yiwa mutum allurar rigakafin cutar hepatitis B ko kuma yana shan magani, kuma ba zai yuwu a tantance ko an warke hepatitis B. A cikin waɗannan lamuran, ana ba da shawarar cewa a maimaita gwajin bayan wata 1;
• Mai da hankali kan anti-hbs mafi girma fiye da 100 mIU / mL - reagent. Wannan maida hankali yana nuna cewa mutum yana da rigakafi daga kwayar hepatitis B, ko ta hanyar allurar rigakafi ko kuma ta hanyar warkar da cutar.

Baya ga kimanta sakamakon gwajin anti-hbs, likita kuma yana nazarin sakamakon gwajin HBsAg. Don haka, yayin lura da mutumin da ya rigaya ya kamu da cutar hepatitis B, sakamakon HBsAg wanda ba ya amsawa da kuma sakamako mai kyau na anti-hbs yana nuna cewa mutumin ya warke kuma babu sauran ƙwayoyin cuta da ke yawo a cikin jini. Mutumin da ba shi da cutar hepatitis B shima yana da sakamako iri ɗaya kuma yawan kwayar anti-hbs ya fi 100 mIU / mL.

Game da HBsAg da anti-hbs masu kyau, ana ba da shawarar a maimaita gwajin bayan kwana 15 zuwa 30, saboda yana iya nuna sakamako mai kyau na ƙarya, samuwar ƙwayoyin cuta (ƙwayoyin rigakafi) ko kamuwa da cuta ta wasu nau'ikan cututtukan hepatitis B ƙwayar cuta.